SciTransfer
Organization

UNIVERSITE DE MONTPELLIER

French research university strong in catalytic materials for CO2 conversion, genomics, and biopolymers — frequently embedded as specialist in large EU consortia.

University research groupmultidisciplinaryFR
H2020 projects
80
As coordinator
12
Total EC funding
€20.4M
Unique partners
977
What they do

Their core work

Université de Montpellier is a major French research university with deep strengths in materials science, catalysis, life sciences, and environmental observation. Their labs develop advanced porous materials and catalysts for CO2 capture and conversion, artificial photosynthesis systems, and biodegradable biopolymers. They also contribute significantly to genomics, regenerative medicine, and earth observation research. In H2020, they frequently served as a specialized knowledge provider embedded within large European consortia, contributing targeted scientific expertise rather than leading project management.

Core expertise

What they specialise in

Advanced materials and catalysis for CO2 capture/conversionprimary
8 projects

Projects A-LEAF (artificial photosynthesis), CELBICON (CO2-to-chemicals), GRAMOFON (graphene aerogel adsorbents), POROUS4APP (nanoporous carbons), and H-CCAT (C-H bond activation) form a strong cluster in catalytic materials.

Fuel cell and hydrogen technologiessecondary
4 projects

VOLUMETRIQ (PEM fuel cell stacks), INSPIRE (fuel cell stack components), and CREATE (hydrogen generation without critical raw materials) show sustained involvement in hydrogen energy.

Biopolymers and sustainable materialssecondary
3 projects

Keywords including biodegradable polymers, bioplastics, biobased materials, and ionomers indicate active work in green polymer science, supported by projects like NoAW (agricultural waste to assets).

Genomics, bioimaging, and regenerative medicinesecondary
5 projects

ImageInLife (coordinator, multilevel bioimaging), RESPINE (disc regeneration with stem cells), and SIFRm (biomedical data indexing) demonstrate life sciences capacity spanning imaging, therapy, and bioinformatics.

Earth observation and ecosystem sciencesecondary
4 projects

ECOPOTENTIAL (ecosystem benefits via earth observation), ERA-PLANET (European observation network), and AQUACOSM (aquatic mesocosm facilities) reflect environmental monitoring expertise.

NAD biology and cancer targetsemerging
2 projects

Recent-period keywords highlight NAD production, NAD signaling, and new cancer targets — indicating a growing research line in molecular biology and oncology.

Evolution & trajectory

How they've shifted over time

Early focus
Earth observation and HPC
Recent focus
Molecular catalysis and genomics

In their early H2020 period (2015–2018), Montpellier focused on high-performance computing, earth observation platforms (ECOPOTENTIAL, ERA-PLANET), and foundational materials work including graphene and nanoporous carbons. By 2019–2021, their focus shifted toward molecular-level science: oxygen evolution reactions for artificial photosynthesis, 3D genomics, NAD signaling pathways, and translational cell biology. The trajectory shows a clear move from infrastructure-scale observation and computing toward precision chemistry and molecular life sciences.

Montpellier is concentrating on molecular-scale innovation — catalytic materials for green chemistry and advanced genomics/cell biology — making them an increasingly strong partner for projects at the chemistry-biology interface.

Collaboration profile

How they like to work

Role: third_party_expertReach: Global62 countries collaborated

Montpellier overwhelmingly operates as a specialist contributor rather than a project leader: only 12 of 80 projects are coordinated, while 31 involve third-party participation — meaning they are frequently brought in by consortium members for their specific lab expertise. With 977 unique partners across 62 countries, they are a high-connectivity hub that works with many different organizations rather than repeating the same partnerships. This makes them easy to integrate into new consortia, but expect them to contribute deep science rather than handle project administration.

An exceptionally wide network spanning 977 unique partners across 62 countries, reflecting their role as a go-to specialist that many different consortia pull in. Their geographic reach is truly global, though the strongest density is within Western European research networks.

Why partner with them

What sets them apart

Montpellier's distinctive feature is the sheer breadth of their third-party engagements — nearly 40% of their H2020 projects are as third parties, meaning major European consortia specifically seek out their labs for specialized contributions. Their rare combination of catalytic materials science (CO2 capture, artificial photosynthesis, MOFs) with strong life sciences (genomics, regenerative medicine) positions them at the chemistry-biology intersection that few universities cover with equal depth. For consortium builders, they offer plug-in scientific excellence without the overhead of a coordination-heavy partner.

Notable projects

Highlights from their portfolio

  • A-LEAF
    EUR 687K for artificial photosynthesis using earth-abundant materials — their largest single-project contribution and central to their catalysis identity.
  • ImageInLife
    Coordinated this MSCA training network in multilevel bioimaging, one of their few leadership roles and a flagship for their life sciences capacity.
  • CELBICON
    EUR 352K for converting captured CO2 into chemicals via electrochemistry and fermentation — exemplifies their cross-disciplinary strength linking chemistry with bioprocessing.
Cross-sector capabilities
Energy — catalytic materials for CO2 capture, hydrogen generation, and artificial photosynthesisHealth — regenerative medicine, stem cell therapy, biomedical data indexingEnvironment — earth observation networks, ecosystem monitoring, aquatic mesocosmsManufacturing — nanoporous materials, biopolymers, graphene-based technologies
Analysis note: 80 projects provide good coverage, though 31 third-party roles lack funding data, which may understate their true financial involvement. The high third-party ratio is genuine and characteristic — not a data artifact.